Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Capsule could reduce need for booster injections
The project is assessing the need for single-shot vaccine delivery in cattle.

Device may revolutionise human and medical sectors

Edinburgh researchers are developing a new device that releases medicine at specific times. It is hoped the device - a capsule that is implanted under the skin - could revolutionise both human and animal medicine.

The project is being delivered by The Roslin Institute and Heriot-Watt University who have been awarded £800k of funding from the Biotechnology and Biological Sciences Research Council (BBSRC).

It is assessing the potential for single-shot vaccine delivery in cattle, thereby reducing the need for booster vaccinations. Researchers say that if the project is successful, it could also be used for antibiotics, chemotherapeutics and other drugs.

The 3D-printed capsule contains a single-shot of vaccine as well as a sugar solution. The sugar pulls water through the wall of the capsure leading to pressure build-up. Eventually the capsule bursts and delivers the vaccine.

“By carefully tailoring the material properties and capsule design, we aim to achieve release at the desired time-point, without needing any intervention, said Dr Ferry PW Melchels, assistant professor at Heriot-Watt’s Institute of Biological Chemistry, Biophysics and Bioengineering.

“This will omit the need for a second visit to the doctor or a second visit from the vet; it will even allow to vaccinate wildlife without having to recapture the animals to give them their booster shots.”

Jayne Hope of The Roslin Institute added: "We are delighted to have been awarded funding from the BBSRC for this joint project with Heriot-Watt University.

"This project will investigate the potential for single-shot vaccine delivery in cattle, thereby reducing the requirement for booster immunisations. This could have a significant impact on the control of infectious diseases in livestock."

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'